Reviews Lymerix


No reviews yet.

Lymerix Drug Description
Lymerix™
Lyme Disease Vaccine (Recombinant OspA)
DRUG DESCRIPTION
LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by Smith Kline Beecham Biologicals. The causative agent of Lyme disease is Borrelia burgdorferi; in North America, all Lyme disease is due to Borrelia burgdorferi sensu stricto. The vaccine contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. No substance of animal origin is used in the commercial manufacturing process. Fermentation media consist primarily of inorganic salts, and vitamins, with small quantities of antifoam (contains silicon), kanamycin sulfate (an aminoglycoside antibiotic), and yeast extract. Silicon and kanamycin are removed to levels below detection (<7 ppm and <10 ppb, respectively). The vaccine is adsorbed onto aluminum hydroxide.
LYMErix is supplied as a sterile suspension in single-dose vials and prefilled syringes for intramuscular administration. The vaccine is ready for use without reconstitution; it must be shaken before administration to ensure a uniform turbid white suspension.
Each 0.5 mL dose of vaccine consists of 30 mcg of lipoprotein OspA adsorbed onto 0.5 mg aluminum as aluminum hydroxide adjuvant. Each dose of the vaccine preparation contains 10 mM phosphate buffered saline and 2.5 mg of 2-phenoxyethanol, a bacteriostatic agent.
The potency of the vaccine is evaluated by immunizing mice with LYMErix and measuring their serum antibody response to OspA by ELISA. Last reviewed on RxList: 7/31/2008




Lymerix Drug Description
Lymerix™
Lyme Disease Vaccine (Recombinant OspA)
DRUG DESCRIPTION
LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by Smith Kline Beecham Biologicals. The causative agent of Lyme disease is Borrelia burgdorferi; in North America, all Lyme disease is due to Borrelia burgdorferi sensu stricto. The vaccine contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. No substance of animal origin is used in the commercial manufacturing process. Fermentation media consist primarily of inorganic salts, and vitamins, with small quantities of antifoam (contains silicon), kanamycin sulfate (an aminoglycoside antibiotic), and yeast extract. Silicon and kanamycin are removed to levels below detection (<7 ppm and <10 ppb, respectively). The vaccine is adsorbed onto aluminum hydroxide.
LYMErix is supplied as a sterile suspension in single-dose vials and prefilled syringes for intramuscular administration. The vaccine is ready for use without reconstitution; it must be shaken before administration to ensure a uniform turbid white suspension.
Each 0.5 mL dose of vaccine consists of 30 mcg of lipoprotein OspA adsorbed onto 0.5 mg aluminum as aluminum hydroxide adjuvant. Each dose of the vaccine preparation contains 10 mM phosphate buffered saline and 2.5 mg of 2-phenoxyethanol, a bacteriostatic agent.
The potency of the vaccine is evaluated by immunizing mice with LYMErix and measuring their serum antibody response to OspA by ELISA. Last reviewed on RxList: 7/31/2008




Lymerix Drug Description
Lymerix™
Lyme Disease Vaccine (Recombinant OspA)
DRUG DESCRIPTION
LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by Smith Kline Beecham Biologicals. The causative agent of Lyme disease is Borrelia burgdorferi; in North America, all Lyme disease is due to Borrelia burgdorferi sensu stricto. The vaccine contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. No substance of animal origin is used in the commercial manufacturing process. Fermentation media consist primarily of inorganic salts, and vitamins, with small quantities of antifoam (contains silicon), kanamycin sulfate (an aminoglycoside antibiotic), and yeast extract. Silicon and kanamycin are removed to levels below detection (<7 ppm and <10 ppb, respectively). The vaccine is adsorbed onto aluminum hydroxide.
LYMErix is supplied as a sterile suspension in single-dose vials and prefilled syringes for intramuscular administration. The vaccine is ready for use without reconstitution; it must be shaken before administration to ensure a uniform turbid white suspension.
Each 0.5 mL dose of vaccine consists of 30 mcg of lipoprotein OspA adsorbed onto 0.5 mg aluminum as aluminum hydroxide adjuvant. Each dose of the vaccine preparation contains 10 mM phosphate buffered saline and 2.5 mg of 2-phenoxyethanol, a bacteriostatic agent.
The potency of the vaccine is evaluated by immunizing mice with LYMErix and measuring their serum antibody response to OspA by ELISA. Last reviewed on RxList: 7/31/2008




Lymerix Drug Description
Lymerix™
Lyme Disease Vaccine (Recombinant OspA)
DRUG DESCRIPTION
LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by Smith Kline Beecham Biologicals. The causative agent of Lyme disease is Borrelia burgdorferi; in North America, all Lyme disease is due to Borrelia burgdorferi sensu stricto. The vaccine contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. No substance of animal origin is used in the commercial manufacturing process. Fermentation media consist primarily of inorganic salts, and vitamins, with small quantities of antifoam (contains silicon), kanamycin sulfate (an aminoglycoside antibiotic), and yeast extract. Silicon and kanamycin are removed to levels below detection (<7 ppm and <10 ppb, respectively). The vaccine is adsorbed onto aluminum hydroxide.
LYMErix is supplied as a sterile suspension in single-dose vials and prefilled syringes for intramuscular administration. The vaccine is ready for use without reconstitution; it must be shaken before administration to ensure a uniform turbid white suspension.
Each 0.5 mL dose of vaccine consists of 30 mcg of lipoprotein OspA adsorbed onto 0.5 mg aluminum as aluminum hydroxide adjuvant. Each dose of the vaccine preparation contains 10 mM phosphate buffered saline and 2.5 mg of 2-phenoxyethanol, a bacteriostatic agent.
The potency of the vaccine is evaluated by immunizing mice with LYMErix and measuring their serum antibody response to OspA by ELISA. Last reviewed on RxList: 7/31/2008




Lymerix Drug Description
Lymerix™
Lyme Disease Vaccine (Recombinant OspA)
DRUG DESCRIPTION
LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by Smith Kline Beecham Biologicals. The causative agent of Lyme disease is Borrelia burgdorferi; in North America, all Lyme disease is due to Borrelia burgdorferi sensu stricto. The vaccine contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. No substance of animal origin is used in the commercial manufacturing process. Fermentation media consist primarily of inorganic salts, and vitamins, with small quantities of antifoam (contains silicon), kanamycin sulfate (an aminoglycoside antibiotic), and yeast extract. Silicon and kanamycin are removed to levels below detection (<7 ppm and <10 ppb, respectively). The vaccine is adsorbed onto aluminum hydroxide.
LYMErix is supplied as a sterile suspension in single-dose vials and prefilled syringes for intramuscular administration. The vaccine is ready for use without reconstitution; it must be shaken before administration to ensure a uniform turbid white suspension.
Each 0.5 mL dose of vaccine consists of 30 mcg of lipoprotein OspA adsorbed onto 0.5 mg aluminum as aluminum hydroxide adjuvant. Each dose of the vaccine preparation contains 10 mM phosphate buffered saline and 2.5 mg of 2-phenoxyethanol, a bacteriostatic agent.
The potency of the vaccine is evaluated by immunizing mice with LYMErix and measuring their serum antibody response to OspA by ELISA. Last reviewed on RxList: 7/31/2008





Other reviews about Lymerix on wordpress

Lawmakers Sever Ties Between CDC And Big Pharma
  by poac
Evelyn Pringle In the wake of overhauling the FDA, lawmakers are also cracking down on conflicts of interest within the Centers for Disease Control. Last month, Representatives, Dr Dave […]


Guess What's in That Vaccine Cocktail?
  by luminaria
We're headed toward winter and barraged with a plethora of advertising that herds us into line to get flu shots. I thought I should post a warning that […]


Prevention
  by lymeaway
Attached ticks should be removed promptly. Protective clothing includes a hat and long-sleeved shirts and long pants that are tucked into socks or boots. Light-colored clothing makes the […]


an idea which makes the way the CDC is working understandable!
  by pixiemb
This is clearly not recent but I find the information a good explanation for me to the actions of the CDC which seemed very strange if they really […]


Никакого заговора нет. Просто бизнес, ну и немного геноцида.
  by Пресс служба РОД С КОБ
Раскрыт фармакологический картель, ответственный за создание пандемического вируса “свиного гриппа” H1N1: официальные свидетельства. ВНИМАНИЕ: В Лос Анджелесе раскрыт фармакологический картель, ответственный за создание и распространение пандемического вируса “свиного гриппа” […]


Media Issues Propaganda to Boost HPV Vaccine Sales and Renewed Confidence Following Children's Deaths
  by Clare Swinney
by Sherri Kane Los Angeles--Vaccine industrialist and media mogul, Mortimer Zuckerman, Editor-in-Chief of US News & World Report, has fraudulently promoted the benefits of vaccines that are killing children, […]


Vaccine Victims Blamed for "National Emergency": Smoking Guns Indict Murdoch's Media in Deadly Corruption
  by Clare Swinney
This article by Dr. Leonard G. Horowitz,  from Tetrahedron, LLC,  Health Science Communications for People Around the World, came in an e-mail dated Nov 12, 09. [caption id="attachment_3599" align="alignright" […]


Protecting Pets from Lyme
  by Rob
Dr. Watts, of Clevengers Corner Veterinary Care Virginia, has a column in today’s Star Exponent warning about Lyme disease and exposure of the disease on your pets.  Much […]


A Crash Course on Lyme Disease
  by Jennifer Sauer
[caption id="attachment_2167" align="alignright" width="300" caption="Image courtesy of www.CDC.gov"][/caption]   Lyme disease, a tick-borne illness, is one of the most misunderstood and controversial diseases of our time. Debate continues over the […]


About Us
  by bricpak
Kathleen Dickson is a former analytical chemist for Pfizer, Groton, (CT, USA) and is a "Lyme Disease" activist/scientist who founded the international advocacy group, ActionLyme, in 1999. Kathleen […]



Other reviews about Lymerix on web:

Learn about the prescription medication Lymerix (Lipoprotein Outer Surface A Vaccine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Lymerix (Lipoprotein Outer Surface A Vaccine) Drug Information ...


Lawyer representing victims of Lymerix, lyme disease vaccine side effects. Call our attorneysnow for a free lawsuit lawsuit. Lymerix Lyme Disease Vaccine Side Effects Attorney


A class action lawsuit, claims that LYMErix, the vaccine manufactured by SmithKline Beecham, which was developed to prevent Lyme disease, can cause an incurable form of autoimmune ... Lyme Vaccine Lawsuit - Drugmaker SmithKline Sued Over LYMErix The ...


Lymerix and Recombinant Ospa Information. News and Information on Lymerix, Attorneys and Lawyers at LegalView.info Lymerix and Recombinant Ospa - Attorney, Lawsuit, Law Suit, Case ...


Lymerix Lyme Disease Vaccine Side Effects: Pennsylvania Medication Lawyers, PA Injury Attorneys, Manufacturer Negligence, Product Liability Claims, Lawsuits Lymerix Lyme Disease Vaccine Side Effects: Pennsylvania Medication ...


Consumer information about the medication LYME DISEASE VACCINE - INTRAMUSCULAR (LymeRix), includes side effects, drug interactions, recommended dosages, and storage information. LYME DISEASE VACCINE - INTRAMUSCULAR (LymeRix) side effects ...


Possible LYMErix vaccine side effects lawsuit. Register your complaint with a lawyer. Lymerix vaccine side effect lawsuit


Lymerix is a vaccination used to prevent Lyme disease, which is caused by the bite of ticks infected with a certain type of bacteria. Lymerix | Injury Claims | Lawsuits | Injury Attorneys & Lawyers


January 8,200l FDA Vaccine Advisory Committee To Whom It May Concern: I am unable to attend the January 3 1 FDA Vaccine Advisory Committee meeting due to a restrictive condition ... LymeRix Vaccine Victim's Stories


Clinical Briefs - March 15, 1999 - American Academy of Family ... The first vaccine against Lyme disease (Lymerix) has been approved by the ... The Web site address for information ... Lymerix





Featured Reviews

Reviews Kenalog 10 Injection

Kenalog 10 Injection Drug Description KENALOG® - 10 INJECTION (triamcinolone acetonide) Injectable Suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL For Intra-articular or Intralesional Use NOT FOR INTRAVENOUS,...
Read More  |  Review This
Reviews Norgestimate and Ethinyl Estradiol

Ortho Tri-Cyclen / Ortho-Cyclen Drug Description ORTHO TRI-CYCLEN® TABLETS ORTHO-CYCLEN® TABLETS (norgestimate/ethinyl estradiol) Patients should be counseled that this product does not protect against HIV infection (AIDS) and...
Read More  |  Review This
Reviews Dianeal PD-2

Dianeal PD-2 Drug Description DIANEAL PD-2 (peritoneal dialysis solution AMBU-FLEX Container For Peritoneal Dialysis For intraperitoneal administration only DRUG DESCRIPTION DIANEAL PD-2 peritoneal dialysis solutions in AMBU-FLEX containers...
Read More  |  Review This
Reviews Tetanus Immune Globulin

BayTet Drug Description BayTet® Tetanus Immune Globulin (Human) Solvent/Detergent Treated 250 Units DRUG DESCRIPTION Tetanus Immune Globulin (Human) BayTet® treated with solvent/detergent is a sterile solution of tetanus hyperimmune...
Read More  |  Review This
Reviews 10% I.V Fat Emulsion

Intralipid 10% Drug Description Intralipid® 10% (10% I.V. Fat Emulsion) In Excel® Container DRUG DESCRIPTION INTRALIPID® 10% (A 10% INTRAVENOUS FAT EMULSION) IS A STERILE, NON-PYROGENIC FAT EMULSION PREPARED FOR INTRAVENOUS...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....